diltiazem hydrochloride (70436-196)

Drug Facts

Product Profile

Brand Name diltiazem hydrochloride

Generic Name diltiazem hydrochloride

Labeler slate run pharmaceuticals, llc

Dosage Form TABLET, EXTENDED RELEASE

Routes

ORAL

Active Ingredients

diltiazem hydrochloride 180 mg/1

Manufacturer

Slate Run Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 70436-196

Product ID 70436-196_44e0c7a1-c1bd-41e2-e063-6294a90a969d

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA216439

Listing Expiration 2026-12-31

Marketing Start 2023-03-20

Pharmacologic Class

Classes

calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a4 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70436196

Hyphenated Format 70436-196

Supplemental Identifiers

RxCUI

830874 830877 830879 830882 830897 830900

UPC

0370436199068 0370436196067 0370436200047 0370436197064 0370436197040 0370436198047 0370436200061 0370436198061 0370436199044 0370436195046 0370436195060 0370436196043

UNII

OLH94387TE

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name diltiazem hydrochloride (source: ndc)

Generic Name diltiazem hydrochloride (source: ndc)

Application Number ANDA216439 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

180 mg/1

source: ndc

Packaging

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-196-04)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-196-06)

source: ndc

Packages (2)

70436-196-04 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-196-04) 70436-196-06 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-196-06)

Ingredients (1)

diltiazem hydrochloride (180 mg/1)

Linked Drug Pages (1)

Diltiazem Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "44e0c7a1-c1bd-41e2-e063-6294a90a969d", "openfda": {"upc": ["0370436199068", "0370436196067", "0370436200047", "0370436197064", "0370436197040", "0370436198047", "0370436200061", "0370436198061", "0370436199044", "0370436195046", "0370436195060", "0370436196043"], "unii": ["OLH94387TE"], "rxcui": ["830874", "830877", "830879", "830882", "830897", "830900"], "spl_set_id": ["f7137458-0db3-7ecd-e053-6394a90a5f95"], "manufacturer_name": ["Slate Run Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-196-04)", "package_ndc": "70436-196-04", "marketing_start_date": "20230320"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-196-06)", "package_ndc": "70436-196-06", "marketing_start_date": "20230320"}], "brand_name": "Diltiazem Hydrochloride", "product_id": "70436-196_44e0c7a1-c1bd-41e2-e063-6294a90a969d", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "70436-196", "generic_name": "Diltiazem Hydrochloride", "labeler_name": "Slate Run Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Diltiazem Hydrochloride", "active_ingredients": [{"name": "DILTIAZEM HYDROCHLORIDE", "strength": "180 mg/1"}], "application_number": "ANDA216439", "marketing_category": "ANDA", "marketing_start_date": "20230320", "listing_expiration_date": "20261231"}